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5-NITROACENAPHTHENE (5-NAN) has
been used as an intermediate fluorescent
whitening agent and a photochemical
agent. From the viewpoint ofprevention
of occupational cancer, our attention has
been focused on the possible carcinogeni-
city of this chemical. Its chemical struc-
tureis showninthe figure. Inourprevious
experiment (Takemura, 1970) myeloid
leukaemias, lymphosarcomata orreticulum
cell sarcomata were produced in the dd
strain female mice that had received this
chemical by intraperitoneal injection for a
period of 18 months.
Furthersignificantresultswereobtained
from our present experiment, inwhich rats
and hamsters were given 5-NAN orally.
MATERIALS AND METHODS
Experiment No. 1
Group 1.-Thirty weanling inbred female
rats ofthe Wistar strain were housed in pairs
in a metal cage and a 25% protein diet
(Oriental Co., Tokyo) containing 1% 5-NAN
was administered to them. As the animals
bec#me debilitated, probably due to the toxic
effect of the 5-NAN one month after the
initiation of the feeding test, the diet was
replaced with the regular one, without the
chemical, for 3 weeks. After this period the
mice were given the diet containing 5-NAN
for a further one month, and as they again
became debilitated the diet was replaced
with the regular one for 3 weeks. At the
end of this period the diet containing the
chemical was given again for an additional 2
months. Thus, the administration period of
the chemical totalled 4 months, with 2
interruptions each of 3 weeks. After this
period the regular diet was given to the rats
until the endofthe experiment. The average
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daily consumption per animal of the diet
containing 5-NAN was 20 g, which implied
that the daily intake of 5-NAN averaged 200
mg per animal. Tap water was given ad
libitum throughout the experiment.
Group 2.-Thirty weanling inbred female
rats of the Wistar strain untreated and
served as controls.
The experimental animals were left to
die or were killed with ether when they were
found to be in poor physical condition or
when recognized macroscopically as having
produced a tumour. Their organs were
examined macroscopically and fixed in 10%
buffered formalin. Histological studies were
made of the organs that showed gross
pathological changes and sections from these
tissues were stained routinely with haema-
toxylin and eosin.
Experiment No. 2
Twenty weanling inbred male rats of the
Wistar strain were housed in the same way as
were the female rats in Experiment No. 1.
They were given the diet containing 1%
5-NAN continuously for 6 months because
the animals had a high tolerance for the
chemical, showing no toxic effects.
Experiment No. 3
The same experimental study as that of
Experiment No. 2 was performed on 24
weanling female and 10 male Syrian golden
hamsters.
RESULTS
Experiment No. 1
5-NAN treatment shortened the sur-
vival time of the test animals when
compared with the controls; this was
probably due to toxic effects of theN. TAKEMURA, C. HASHIDA AND M. TERASAWA
CH2-CH2
NO,
5-nitroacenaphthene
FiG.-The chemicalstructure of5-nitroacenaphthene
chemical. The treatment significantly
reducedthe body weight ofthe testanimals
when compared with the controls, and it
also turned the hair of the treated rats
yellowish but this was not seen in the
controls.
Of the 30 female rats used in Group 1,
18 died, probably of poisoning by 5-NAN
or from other causes, without developing
a tumour and 12 lived more than 200
days after the initiation of the feeding
experiment. The first autopsy on a rat
recognized as having developed a tumour
was performed 280 days after the initia-
tion of the feeding test, and the last
autopsy was performed 500 days after the
start of the feeding experiment. During
the period between the 280th and the 500th
day of the experiment, all the live rats
developed malignant tumours, as shown
TABLE.-5-Nitroacenaphthene Feeding
Experiment
Survival time
(days)
282 Squamous cell carcinoma in ear
(luct
360 Intraductal carcinoma in breast
and adenocarcinoma in small
intestine
375 Adenocarcinoma in small intestine
379 Adenocarcinoma in small intestine
379 Intraductal carcinoma in breast
and adenocarcinoma in small
intestine
379 Intraductal carcinoma in breast
381 Rhabdomyosarcoma, intraductal
carcinoma in breast and adenocar-
cinoma in small intestine
381 Adenocarcinoma in small intestinie
428 Squamous cell carcinoma in ear
duct andl adenocarcinoma in small
intestine
438 Adenocarcinoma in small intestine
500 Intraductal carcinoma in breast
and adenocarcinoma in small
intestine
in the Table. The tumours were classi-
fied as follows: 1 case of rhabdomyo-
sarcoma, 2 of sebaceous, squamous cell
carcinomata in the ear duct, 5 of intra-
ductal carcinoma in the breast and 10
of adenocarcinoma in the small intestine.
Of the 30 control female rats (Group
2), 29 lived more than 500 days but they
did not develop any malignant tumours.
Experiment No. 2
The experimental male rats did not
lose body weight and grew normally.
They were left to die or were killed with
ether 500 days after the initiation of the
feeding test. They were autopsied and
examined, and no malignant tumour was
found. It appeared that there was a
definite sex difference in the production
of cancer by the administration of 5-NAN.
Experiment No. 3
In the case of the experimental female
hamsters, the 5-NAN treatment reduced
theirbodyweight when compared with the
controls. Thirteen ofthe 24 experimental
female hamsters survived 270 days after
the start of the feeding test, and oholan-
giomata were observed histologically in
7 of the 13 survivors. No tumours
were recognized in the 20 control female
hamsters.
Of the 10 male hamsters that had
received the 5-NAN treatment. 7 lived
more than 270 days after the initiation
of the feeding experiment, but no tumour
was observed in them.
DISCUSSION
Walpole, Williams, and Roberts (1952)
discovered that 2',3-dimethyl-4-aminobi-
phenyl gave a high incidence of cancer in
the intestine, especially in the colon, in
rats. The mechanism by which tumours
were produced in the large intestine was
discussed by Weisburger (1971) from the
viewpoint of metabolism of the chemical.
He points out that the metabolism ofsuch
aromatic amines as 2',3-dimethyl-4-
aminobiphenyl or 4-amninobiphenyl
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involves N-hydroxylation, conjugation
of the metabolite with glucuronic acid,
secretion of the conjugate in bile, and
liberation of the free N-hydroxy com-
pound, the postulated active intermediate,
by action of bacteria flora in the gut.
As observed in the female rats in our
feeding experiment of 5-NAN, adenocar-
cinomata were found in the small intestine
and not in the colon. This suggests that
5-NAN given orally to female rats is
metabolized in the liver into another
derivative of 5-NAN, which may be
secreted in bile and act as a carcinogenic
intermediate to the epithelial tissues ofthe
small intestine. The result of the study
on the carcinogenic metabolite will be
reported later.
The authors are grateful to Drs G. M.
Bonser and D. B. Clayson of Leeds,
England, for their encouragement in this
work.
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